b
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Product introduction:
Isradipine, a new dihydropyridine calcium channel blocker, was developed by Swiss Sandoz company and first introduced to the market by Ciba Jiaji company in February 1989. It selectively acts on vascular smooth muscle to expand the vascular bed of coronary artery, cerebrovascular, skeletal muscle and other arteries, so as to reduce blood pressure and alleviate angina pectoris. It has a slight inhibitory effect on sinoatrial node, but does not affect atrioventricular node conduction. It is suitable for the treatment of essential hypertension and cardiac insufficiency.
CAS：75695-93-1
Molecular formula: C19H21N3O5
Molecular weight: 371.39
Structure: 
Appearance: yellow solid
Product purpose:The new calcium antagonist has the effects of reducing blood pressure, anti angina pectoris and anti arteriosclerosis. It is used to treat essential hypertension, angina pectoris and arteriosclerosis.
Manufacturing
